During the past decade, Clinica IMQ Zorrotzaurre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica IMQ Zorrotzaurre" #1 collaborator was "Apices Soluciones S.L." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Sistemas Genómicos" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinica IMQ Zorrotzaurre" are "Bladder Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Clinica IMQ Zorrotzaurre" in a lesser frequency.

Most popular intervention types in "Clinica IMQ Zorrotzaurre" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (1 trials), "Durvalumab" (1 trials), "Olaparib" (1 trials), "Radiotherapy" (1 trials) and "approved GnRH agonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica IMQ Zorrotzaurre" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinica IMQ Zorrotzaurre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinica IMQ Zorrotzaurre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica IMQ Zorrotzaurre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".